Anderson Hoagland & Co’s Keysight KEYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-21,220
Closed -$2.81M 128
2023
Q3
$2.81M Sell
21,220
-62
-0.3% -$9.18K 0.38% 71
2023
Q2
$3.56M Buy
21,282
+113
+0.5% +$17.5K 0.46% 51
2023
Q1
$3.42M Sell
21,169
-63
-0.3% -$10.7K 0.49% 53
2022
Q4
$3.75M Sell
21,232
-241
-1% -$41.1K 0.55% 47
2022
Q3
$3.38M Buy
21,473
+200
+0.9% +$32K 0.54% 49
2022
Q2
$3.04M Buy
21,273
+159
+0.8% +$22.6K 0.46% 57
2022
Q1
$3.33M Buy
21,114
+8
+0% +$1.33K 0.43% 56
2021
Q4
$3.7M Sell
21,106
-1,036
-5% -$194K 0.49% 54
2021
Q3
$3.64M Buy
22,142
+101
+0.5% +$17K 0.46% 56
2021
Q2
$3.4M Sell
22,041
-365
-2% -$53K 0.43% 59
2021
Q1
$3.21M Sell
22,406
-543
-2% -$77K 0.45% 59
2020
Q4
$3.03M Buy
22,949
+1
+0% +$115 0.48% 58
2020
Q3
$2.31M Buy
22,948
+1,002
+5% +$98.4K 1.1% 24
2020
Q2
$2.21M Buy
21,946
+562
+3% +$55.2K 1.04% 27
2020
Q1
$1.75M Buy
21,384
+3,501
+20% +$332K 1.08% 26
2019
Q4
$1.91M Buy
17,883
+221
+1% +$22.6K 1.08% 24
2019
Q3
$1.71M Sell
17,662
-404
-2% -$37.4K 1.04% 28
2019
Q2
$1.36M Buy
+18,066
New +$1.53M 0.84% 36

Other funds holding KEYS

Anderson Hoagland & Co's KEYS Position: Q4 2023 in Review

Anderson Hoagland & Co sold out of Keysight (KEYS) in Q4 2023, closing a stake of 21,220 shares — an estimated $2.81M sold.

Anderson Hoagland & Co first reported a position in KEYS in Q2 2019 and held it in 18 quarters. The position peaked at $3.75M in Q4 2022. 880 funds tracked by Wall St. Rank hold KEYS as of Q4 2023.

  • Anderson Hoagland & Co reported no remaining Keysight position as of Q4 2023 after selling out during the quarter.
  • Anderson Hoagland & Co sold 21,220 Keysight shares in Q4 2023, an estimated $2.81M.
  • Anderson Hoagland & Co first reported a position in Keysight in Q2 2019 and held it in 18 quarters.
  • Anderson Hoagland & Co's Keysight position peaked at $3.75M in Q4 2022.
  • 880 funds tracked by Wall St. Rank held Keysight as of Q4 2023.

Based on Anderson Hoagland & Co's 13F filing for Q4 2023, filed 17 Jan 2024.